RSS

DHI D.R. Horton Inc.

Last Post: 05/26/25
Followers: 1
Posts Today: 0
Views Today: 1434

DHI Stock Quote & Tools

$145.5500 ▲ +1.1000 (+0.76%) As of Nov 13, 4:00 PM EST
Last145.5500
$ Chg1.1000
Open144.0000
High145.6200
Beta1.3544
Year High170.785
Market Cap40.71B
P/B Ratio1.58
EPS10.49
Avg Vol (30d)3.34M
Volume2.71M
% Chg+0.76%
Prev Close144.4500
Low143.0100
VWAP145.16307
Year Low130.400
Total Shares279.70M
Shares Out279.70M
Float279.70M
ExchangeNYSE
Consumer Discretionary Residential Construction

DHI Stock Message Board Discussion

Top 10 Most Recent News Articles

Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 130

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 163

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
NeuroPace Faces Investigation After Revenue Forecast Cut

Updated Category News Views 49

NeuroPace Revenue Drama: A Blow to Investor Confidence How the mighty have stumbled—or so it feels to the folks who put their bucks into NeuroPace, Inc. (NASDAQ: NPCE). It's tough to swallow: they cut their 2026 revenue forecast from a hopeful $99.5-$101.5 million to a sobering $91-$92 million. Just one quarter apart those projections are, like a cruel twist of fate...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
NaLA Pushes for Stronger Lifeline Fraud Measures

Updated Category News Views 89

Here's the thing about the Lifeline program: it's meant to be a lifeline, not a loophole for the crafty and unscrupulous. The National Lifeline Association (NaLA) is slamming the table, demanding that the Senate Commerce Committee put some real muscle into preventing fraud. Why the Urgency on Lifeline Fraud? NaLA’s got its sights on a more robust defensive line against...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 205

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
ArcSpan AMS Nabs Top Honors at The Wires 2026

Updated Category News Views 142

ArcSpan Takes Center Stage with Prestigious Accolade ArcSpan just bagged the Best New Product or Service: Sell Side award at The Wires 2026. This ain't your average pat on the back. Taking place at the ritzy One Marylebone in London, this win springs from an event that celebrates the crème de la crème of digital advertising innovation. A Solid Win Amid The Changing Ad...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
The Melt Grabs Top Spot in Burger Ratings War

Updated Category News Views 107

Burger Battle: The Melt Claims Victory When you're in the cutthroat world of fast-casual dining, grabbing the top spot on any list is no small potatoes. The Melt did just that, snatching the title of America’s Highest-Rated Burger Spot. Based on an in-depth analysis of Google and Yelp reviews, folks have spoken, loud and clear, over the past two years. It's a world...

Continue Reading

Top 5 Most Recently Viewed Articles

Easterly ROCMuni Fund Investors: Understanding Your Rights

Updated Category News Views 110

Understanding the Easterly ROCMuni Fund Situation The Easterly ROCMuni High Income Municipal Bond Fund, formerly known as Principal Street High Income Municipal Fund, has recently come under scrutiny regarding its investment practices. Investors in the fund are encouraged to reach out to legal professionals to discuss potential claims related to significant financial...

Continue Reading
Is Bitcoin Ready for a Breakout Amid Bullish Sentiment?

Updated Category News Views 111

Bitcoin's Current Market Position Bitcoin (BTC/USD) is currently positioned near $115,000, just a day before significant decisions regarding interest rates by the Federal Reserve. Expectations are high, as many anticipate a rate cut of 25 basis points, which is igniting market discussions and predictions. Current Market Sentiment Recent data from Santiment highlights an...

Continue Reading
Nyxoah's Upcoming Presentation at Healthcare Conference Revealed

Updated Category News Views 168

Nyxoah to Present at Healthcare Conference Nyxoah SA, a leader in medical technology focused on treating Obstructive Sleep Apnea (OSA), is poised to showcase its advancements at an upcoming prominent event. The company will take part in the Piper Sandler 36th Annual Healthcare Conference, scheduled for December 4. This notable event is set to provide a platform for Nyxoah...

Continue Reading
Keros Therapeutics Welcomes Dr. Yung H. Chyung as CMO

Updated Category News Views 176

Keros Therapeutics Welcomes New Leadership Keros Therapeutics, Inc. (NASDAQ: KROS) is making waves with the recent appointment of Dr. Yung H. Chyung as their new Chief Medical Officer. This pivotal move signals the company's commitment to advancing its innovative drug development efforts, especially as they gear up for critical clinical milestones. Keros is known for its...

Continue Reading
Nestlé's Strategic Shake-Up: Leadership Changes and Impacts

Updated Category News Views 303

Unexpected Leadership Change at Nestlé In a surprising turn of events, Nestlé has dismissed its Chief Executive Officer, Laurent Freixe, due to his failure to communicate a romantic relationship with an employee who worked under his supervision. This decision highlights the strict adherence to corporate governance rules that Nestlé aims to uphold. Philipp Navratil...

Continue Reading